These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9284858)

  • 1. Using fuzzy logic to predict response to citalopram in alcohol dependence.
    Naranjo CA; Bremner KE; Bazoon M; Turksen IB
    Clin Pharmacol Ther; 1997 Aug; 62(2):209-24. PubMed ID: 9284858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in response to citalopram in men and women with alcohol dependence.
    Naranjo CA; Knoke DM; Bremner KE
    J Psychiatry Neurosci; 2000 May; 25(3):269-75. PubMed ID: 10863887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poorer Drinking Outcomes with Citalopram Treatment for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Charney DA; Heath LM; Zikos E; Palacios-Boix J; Gill KJ
    Alcohol Clin Exp Res; 2015 Sep; 39(9):1756-65. PubMed ID: 26208048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence.
    Muhonen LH; Lönnqvist J; Juva K; Alho H
    J Clin Psychiatry; 2008 Mar; 69(3):392-9. PubMed ID: 18348597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of citalopram and a brief psycho-social intervention on alcohol intake, dependence and problems.
    Naranjo CA; Bremner KE; Lanctôt KL
    Addiction; 1995 Jan; 90(1):87-99. PubMed ID: 7888983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fuzzy logic pharmacokinetic modeling: application to lithium concentration prediction.
    Sproule BA; Bazoon M; Shulman KI; Turksen IB; Naranjo CA
    Clin Pharmacol Ther; 1997 Jul; 62(1):29-40. PubMed ID: 9246017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining motivational interviewing with compliance enhancement therapy (MI-CET): development and preliminary evaluation of a new, manual-guided psychosocial adjunct to alcohol-dependence pharmacotherapy.
    Heffner JL; Tran GQ; Johnson CS; Barrett SW; Blom TJ; Thompson RD; Anthenelli RM
    J Stud Alcohol Drugs; 2010 Jan; 71(1):61-70. PubMed ID: 20105415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of serotonin (5-hydroxytryptamine) reuptake inhibitors in the treatment of alcoholism.
    Lejoyeux M
    Alcohol Alcohol Suppl; 1996 Mar; 31(1):69-75. PubMed ID: 9845041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of alcohol dependence in patients with co-morbid major depressive disorder--predictors for the outcomes with memantine and escitalopram medication.
    Muhonen LH; Lahti J; Sinclair D; Lönnqvist J; Alho H
    Subst Abuse Treat Prev Policy; 2008 Oct; 3():20. PubMed ID: 18834506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of citalopram on alcohol intake in heavy drinkers.
    Balldin J; Berggren U; Engel J; Eriksson M; Hård E; Söderpalm B
    Alcohol Clin Exp Res; 1994 Oct; 18(5):1133-6. PubMed ID: 7847595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citalopram in the treatment of alcoholism: a double-blind placebo-controlled study.
    Tiihonen J; Ryynänen OP; Kauhanen J; Hakola HP; Salaspuro M
    Pharmacopsychiatry; 1996 Jan; 29(1):27-9. PubMed ID: 8852531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive aripiprazole therapy with escitalopram in patients with co-morbid major depressive disorder and alcohol dependence: clinical and neuroimaging evidence.
    Han DH; Kim SM; Choi JE; Min KJ; Renshaw PF
    J Psychopharmacol; 2013 Mar; 27(3):282-91. PubMed ID: 23325372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citalopram: a comprehensive review.
    Pollock BG
    Expert Opin Pharmacother; 2001 Apr; 2(4):681-98. PubMed ID: 11336616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fluvoxamine in the treatment of depressive disorders in alcohol dependence: results of randomized open-label comparative study].
    Vinnikova MA; Severtsev VV; Komarov SD; Vdovin AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(12):57-62. PubMed ID: 35041313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of serotonin (5-hydroxytryptamine) reuptake inhibitors in the treatment of alcoholism.
    Lejoyeux M
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():69-75. PubMed ID: 8737004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Citalopram on Cue-Induced Alcohol Craving and Thalamic D2/3 Dopamine Receptor Availability.
    Zorick T; Okita K; Mandelkern MA; London ED; Brody AL
    Int J Neuropsychopharmacol; 2019 Apr; 22(4):286-291. PubMed ID: 30753467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of combined citalopram and naltrexone for nonabstinent outpatients with co-occurring alcohol dependence and major depression.
    Adamson SJ; Sellman JD; Foulds JA; Frampton CM; Deering D; Dunn A; Berks J; Nixon L; Cape G
    J Clin Psychopharmacol; 2015 Apr; 35(2):143-9. PubMed ID: 25679122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of selective serotonin reuptake inhibitors in reducing alcohol consumption.
    Naranjo CA; Knoke DM
    J Clin Psychiatry; 2001; 62 Suppl 20():18-25. PubMed ID: 11584871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome.
    Tack J; Broekaert D; Fischler B; Van Oudenhove L; Gevers AM; Janssens J
    Gut; 2006 Aug; 55(8):1095-103. PubMed ID: 16401691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.